Trial Profile
An Open Label, Single Dose Trial With Two Groups Comparing the Pharmacokinetics of Liraglutide in Young Versus Elderly Healthy Subjects of Both Sexes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 02 Apr 2015 New trial record